Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

Retained duplications and deletions of CYP2C genes among primates

(2018) Morgan E. Chaney et al.   MOLECULAR PHYLOGENETICS AND EVOLUTION

Widespread Use of Prescription Nonsteroidal Anti-Inflammatory Drugs Among U.S. Army Active Duty Soldiers

(2017) Leila A. Walker et al.   MILITARY MEDICINE

Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects

(2015) Yun-Jeong Lee et al.   ARCHIVES OF PHARMACAL RESEARCH

Effect of gender andCYP2C9andCYP2C8polymorphisms on the pharmacokinetics of ibuprofen enantiomers

(2015) Dolores Ochoa et al.   PHARMACOGENOMICS

CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug

(2015) Silvia Vogl et al.   PLoS One

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing

(2014) K E Caudle et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Individual NSAIDs and Upper Gastrointestinal Complications

(2013) Jordi Castellsague et al.   DRUG SAFETY

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population

(2013) Yingjun Zhou et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals

(2013) Hye-In Lee et al.   Pharmacogenetics and Genomics

Effects of the CYP2C9*1/*13 Genotype on the Pharmacokinetics of Lornoxicam

(2011) Chang-Ik Choi et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

(2011) Anne-Marie Schjerning Olsen et al.   CIRCULATION

Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga

(2010) Tilo Grosser et al.   Annual Review of Medicine

Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use

(2009) T. Gorski et al.   BRITISH JOURNAL OF SPORTS MEDICINE

Global variation in CYP2C8–CYP2C9 functional haplotypes

(2009) William C Speed et al.   PHARMACOGENOMICS JOURNAL

Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis

(2008) Jonatan D. Lindh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data

(2008) Makiko Kusama et al.   PHARMACEUTICAL RESEARCH